Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : AAV00206Z
Serotype : AAV Serotype 6 Storage : -80 ℃
Titer: Size:
| Cat. No. | AAV00206Z |
| Description | AAV serotype 6 particles contain codon-improved Cre (iCre) under CMV promoter. |
| Serotype | AAV Serotype 6 |
| Titer | Varies lot by lot, typically ≥1x10^12 GC/mL |
| Size | Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots. |
| Endotoxin | Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance. |
| Purity | AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE. |
| Sterility | The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities. |
| Empty vs. Full Capsids | Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods. |
Adeno-associated virus (AAV) was identified as a contaminant in adenoviral (AdV) preparations more than 50 years ago. Since then, AAV has become a platform for the development of one of the most promising gene delivery tools to date. This virus is a unique member of the Parvoviridae family in that AAV is non-pathogenic to humans, relies on the presence of a non-associated helper virus for efficient replication ("Dependoparvovirus"), and packages sense and antisense versions of its single-stranded 4.7 kb viral DNA into a non-enveloped protein capsid in a 1:1 ratio. In addition to the first AAV serotype to be vectorized, serotype 2 (AAV2), 12 other serotypes and more than 100 variants have been isolated from human and non-human sources.
Although serotypes vary in genome length and amino acid composition, all serotypes have in common the inverted terminal repeats (ITRs) that make up the 5' and 3' ends of the genome. These sequences serve as replication origins and packaging signals and are the only viral DNA elements that need to be maintained in cis in AAV vectors. In addition, the viral genome encodes Rep proteins, a family of nonstructural proteins involved in replication, genome packaging, transcriptional control, and integration, the capsid assembly activating protein (AAP), and three different capsid proteins (VP1, VP2, and VP3). The viral coding information is replaced by the transgene expression cassette in AAV vectors but is provided in trans during viral vector production.
Calcineurin is a ubiquitously expressed central Ca2+-responsive signaling molecule that mediates acute pancreatitis, but its role is poorly understood. Here, researchers compared the effects of hematopoietic and pancreatic expression of calcineurin in mouse models of pancreatitis and pancreatitis-associated lung inflammation. Mice with hematopoietic-specific deletion of CNB1 had the same degree of local pancreatic inflammation as control mice after penicillin administration or radiocontrast injection into the pancreatic bile duct. Cnb1UBC△/△ mice or mice with pancreatic-specific deletion of CNB1 had less severe pancreatitis and reduced pancreatic inflammation after penicillin administration or radiocontrast injection into the pancreatic bile duct compared with control mice. NFAT was activated in pancreas of Swiss Webster mice given caerulein or infusions of radiocontrast into biliopancreatic ducts. Blocking the interaction between calcineurin and NFAT did not reduce pancreatic acinar cell necrosis induced by penicillin or radiocontrast infusion. Mice with hematopoietic-specific but not pancreatic-specific CNB1 deletion had reduced neutrophil infiltration in the lungs. Neutrophil chemotaxis and reactive oxygen species production were reduced after incubation with a calcineurin inhibitor. These findings suggest that the protective effects of blocking or deleting calcineurin against pancreatitis are mediated by its source of expression.
To compare the protective effects of calcineurin expression within the pancreas, the researchers investigated the effects of pancreas-specific calcineurin deficiency on the pancreatitis response. Pancreatic-specific calcineurin deficiency was induced in Cnb1f/f mice by intraductal infusion of adeno-associated virus 6 (AAV6) containing enhanced Cre recombinase (iCre) driven by the ubiquitous cytomegalovirus (CMV) promoter (Figure 1A). Intraductal infusion of AAV6-CMV-iCre was performed in LSL-tdTomato reporter mice and strong pancreas-specific red fluorescence was observed throughout the pancreas, indicating widespread expression of iCre. As expected, CNB1 protein levels were reduced in the pancreas but not in BM cells (Figure 1B). During penicillin hyperstimulatory pancreatitis, mice with pancreas-specific CNB1 deficiency (Cnb1Panc∆/∆) exhibited significantly reduced pancreatic histological damage (Figure 1C), edema threshold (Figure 1D), and inflammatory infiltrate (Figure 1E). No sex differences in these parameters were observed with or without pancreas-specific Cnb1 deficiency. Neutrophil infiltration, assessed by pancreatic MPO immunostaining, was significantly reduced after pancreas-specific CNB1 deficiency (Figure 1E), whereas macrophage infiltration (by F4/80) was not different. These results suggest that pancreatic calcineurin selectively affects neutrophil infiltration.
Figure 1. During caerulein hyperstimulation pancreatitis (CER), pancreas-specific deletion of CNB1 largely prevents localized pancreatic injury and systemic inflammation, but it does not affect distant organ damage. (Wen L, et al., 2020)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Reproducibility is key in our line of work, and the AAV6-CMV-iCre product has not disappointed. We’ve been able to reproduce our results across multiple experiments and batches, ensuring the reliability of our data and confidence in our findings.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.